FDA Approved First Migraine Prevention Device

Today the FDA announced their ruling on an innovative and new device that many people have been eagerly awaiting. The Cefaly is essentially a headband that can be worn to prevent migraines from developing, which would bring a significant amount of relief to the millions of people that suffer from regular migraines. The way it operates is very simple too, a self adhesive electrode sticks to the user’s forehead and sends well timed and directed electric pulses to control the onset of a migraine.

Currently the device is not available in the United States, but thanks to the FDA’s approval it will likely soon become much more available. The Cefaly is still going to remain a prescription only device, so unless your doctor says you need it you’re not going to be able to get one. The device is also only supposed to be worn for a maximum of 20 minutes per day but many doctors and researchers say that is far and beyond enough time given just how effective it is. This is absolutely great news for the millions of migraine sufferers, hopefully it’ll hit shelves soon and start making people feel a whole lot better.

This week the FDA officially approved a much anticipated diabetes drug that has been going through screening for quite some time. The drug was designed specifically as a type 2 diabetes treatment and according to the FDA it is now acceptable to sell to the public, which is absolutely great news for millions of diabetes sufferers. What makes Farxiga different from other medication is the way it works, rather than simply treating the issue, this new medication directly deals with the blood sugar generation system.

As a whole this is great news for anyone that suffers from type 2 diabetes. The drug has been proven to be successful, incredibly effective, and it is now going to be available to everyone. Doctors are very excited that Farxiga is now an approved medication and they’re likely to begin recommending it to a large number of patients in the very near future. Overall all type 2 diabetes patients are eligible to use the new drug and they might find that it is more effective and more affordable than current options, making it a big step forward. This is just another step forward in medicine that will likely be a big deal to millions of people around the world in the coming years.

Processed foods are obviously a big part of the market and they’re unlikely to go away any time soon, unfortunately they’re also incredibly unhealthy in many cases. The good news is that today the FDA announced that they’re officially proposing new regulations that should dramatically improve the healthiness of processed food as a whole.

Currently many processed foods contain very high levels of trans fats and according to essentially everyone they’re absolutely the least healthy thing that a person can eat. Based on a variety of recent health studies the FDA is concluding that trans fats are not safe for human consumption and as a result they’re proposing to ban them from food entirely. This is absolutely great news because this change alone could have a noticeable impact on America’s obesity problems. Obviously this isn’t enough to completely resolve the problem but doctors, health experts, and everyone else agree that the FDA definitely needs to work hard at making this ban happen.

The FDA is planning to setup a committee to begin weighing the possibilities of banning trans fats and many experts feel that it will likely happen in soon. This is great news for everyone, assuming the ban passes, and it’ll definitely establish a new standard for healthy meal options.

Breast cancer is one of the leading killers in much of the world, it is also the cancer that generally received the most research funding and as such doctors are hopeful there will be a treatment available soon. Well an FDA announcement this week definitely shows that some very positive progress has been made in that regard. According to the FDA, multiple patients that have been given a new drug in a trial run have shown very promising results.

This is absolutely amazing news because it is really the only step towards a successful treatment in the recent future. The drug was designed to be used as a treatment prior to surgery, making it the least invasive option and the results according to doctors were phenomenal. In the multiple trial patients across the United States the new drug was used prior to any type of surgery and it was found that the drug reduced tumor size by a noticeable amount. This is a big accomplishment according to doctors because it greatly reduces to damage when surgery is needed, plus it helps the body recover faster.

At this point the drug is obviously still experimental but doctors are hopeful that this FDA study will lead to more treatments soon. Many doctors are hopeful that a larger study will be conducted sometime this year.

This week the United States Food and Drug Administration officially began implementing a wide variety of changes that were planned for 2013. The overall goal behind the FDA’s new policies and procedures is to reduce the chances of a major food borne sickness breakout from happening. This change was pushed for because of the numerous food illness outbreaks in 2012 and many experts say that these changes will surely be great news for millions of Americans that could have possibly been affected by an outbreak.

There are hundreds of other changes being implemented as well that are entirely focused on increasing food safety. This is obviously great news because it should in fact lead to better food quality and regulation while at the same time reducing risks. The FDA is planning to have consistent checkups on these changes to make sure things are being done properly and they are hopeful that by the end of the year there will be measurable improvements in food safety.

These FDA changes are great news for all Americans because in the past few years there have been thousands of deaths due to poorly regulated food sales. The FDA is dedicated to putting a stop to this and these changes are sure to be a big success according to most experts.

Epilepsy affects a significant number of people around the globe, many of which are young children. Unfortunately for years now there has been no approved medication for children under the age of 12, but today that has all changed thanks to the FDA’s approval of Fycompa.

Fycompa has been in testing for years and now that it has received FDA approval it will finally be on the market for doctors to prescribe. The medication showed a very significant reduction in symptoms and seizures for children under 12 years old, which is precisely what lead to the eventual approval of the drug. Doctors and researchers have been pushing for Fycompa’s approval for quite some time now and now that it has finally been approved it will likely be available in the very near future.

This is absolutely great news for parents of children with epilepsy as it might finally be the medication they’ve been waiting for. It is not often that a major drug breakthrough comes around and this might be a very big deal for millions of people. In the coming months doctors are expected to continue reporting on the effectiveness and success of the drug with real world patients. Doctors are incredibly happy with the FDA’s approval and are hopeful that it will perform as well in the real world as it has in testing.

A medical study released this week shows that some time in the near future suffers of the debilitating disease, multiple sclerosis, may have a promising treatment. Currently around half a million people in the USA alone are affected by MS and millions more worldwide suffer, which is precisely why this treatment is such good news. The new drug, Myelin, is an oral pill rather than injection which is what makes it so unique.

Currently there are no oral treatments for MS that are effective, making Myelin the best option if it gets approved. The important thing is that Myelin was incredibly effective at treating MS and reducing symptoms during the medical trials so if it becomes publicly available it could improve the lives of millions of people.

The FDA is going to be hearing the case for Myelin sometime soon and most analysts predict it will likely be approved for use. If that is the case then it will hopefully be available on shelves sometime before the end of the year, but at this point it is absolutely impossible to say for sure. Regardless, doctors are incredibly happy with how well Myelin has performed in all medical trials and will continue to fight until it has been approved or improved enough o finally be approved for use as it is the best option on the market right now.

Today the FDA made a landmark approval in the fight against HIV and AIDS. The new drug that was approved is the first of its kind and nearly all medical analysts agree that it will absolutely be the most monumental step forward in recent years.

HIV and AIDS are currently affecting millions and millions of people around the world and while there are effective prevention methods, none of them are actual medical prevention methods. This is precisely why doctors have been trying to come up with a medical solution and today’s FDA approval marks the day that a true medical prevention to HIV has finally become a reality.

The new drug is not 100% effective but the FDA was more than happy to approve it with an approximately 75% affectivity rate. The fact that this is truly the first drug of its kind is what makes this such amazing news and it once again goes to show that medical research is in fact making progress while the world watches. The drug will likely be available sometime in the near future but for now it is simply amazing news that the drug has been approved and will be available soon. HIV and AIDS are still an ongoing battle for millions but this may help bring that battle to a close in the future.

For the past six months Pfizer, a leading drug company, has been selling a drug in Europe that treats a rare and deadly disease. The drug has received dozens of approvals around the world and now that it has seen some real world use the drug has finally spread to the United States. Proponents for the drug claim that it could save countless lives each year and as a result the FDA is now entering the first stage of possibly approving the drug for use in America.

The drug treats a relatively uncommon neurological disease but many doctors and analysts feel it might actually be able to treat or reduce the effects of many other similar disease. Pfizer has, for many reasons, been pushing for the drug to be available in America and now that the FDA is looking at it we might be one step closer to making that a reality.

This is great news for thousands of people directly affected by the disease, but more importantly it shows that around the world medical expertise and research is being shared and expanded. Medicines are treating new diseases every single day and as the years pass it is only a matter of time before some sort of viable medicine becomes available for any number of major issue. The FDA has not yet said when they will begin the proceedings but it is expected to begin sometime in the coming month.

Heart valve failure is a relatively common issue suffered by thousands of people every single year. Unfortunately at this point the only viable solution to fix the problem is extensive surgery requiring hours of precise work, but now there may be another great alternative available.

The new system is called a Sapien Heart Value and the creators of the device say that it works just as well as traditional heart valves but does not require nearly as intensive of a surgical procedure. Obviously there is still surgery involved but the amazing thing is that the significant reduction in surgery invasiveness also leads to significantly reduced healing times.

The FDA just began hearing the case for the heart valve but preliminary results look good. This could be absolutely great news for the thousands of patients that are treated each year for heart value failure, especially since most analysts believe the FDA will soon approve the new system. Saving recovery time and reducing the surgical risk are two of the biggest motivating factors of most medical research and that is exactly what has been accomplished with this new heart value, this is absolutely great news and in the future it will likely continue to spread to other surgical operations. The possibilities are endless and it is amazing to see that medical research is finally beginning to cut down on the severity of most major surgeries.